Dr. Ruben Agabyan is a leading researcher in structure-based drug discovery, specializing in target identification and protein modeling. With an M.S. in Molecular and Chemical Biophysics and a Ph.D. in Protein Structure Prediction, he has made significant contributions to the field.

Agabyan's research focuses on developing novel technologies for drug discovery, including the creation of the Pocketome for target profiling and pharmacology prediction. He has received multiple awards for his work, including two CapCure awards for prostate cancer research and recognition as a top-performing faculty member.

In addition to his research, Agabyan has held leadership roles at institutions such as the Skirball Institute of Biomolecular Medicine and Novartis Institute. He is also actively involved in teaching pharmaceutical sciences and drug development.

Overall, Dr. Ruben Agabyan's innovative contributions have advanced the field of drug discovery, leading to the development of promising therapeutic interventions.